Palanisamy Vasudhevan | Cellular Stress Response | Best Researcher Award

Published on by Cell Biologist

Dr. Palanisamy Vasudhevan | Cellular Stress Response | Best Researcher Award

Dr. Palanisamy Vasudhevan , Chengdu University of Technology , China

Palanisamy Vasudhevan is a highly accomplished researcher with nine years of experience in environmental science, specializing in soil ecology, phytoremediation, and environmental remediation. Currently a Post-Doctoral Fellow at the State Key Laboratory of Geohazard Prevention and Geoenvironment Protection in Chengdu, China, he has demonstrated expertise in the bioremediation of chlorinated aromatic contaminants, heavy metal pollution, and the utilization of biocatalytic enzymes in various applications. He has contributed significantly to understanding the environmental risks posed by heavy metals and their impact on ecosystems, particularly in agricultural contexts. With a strong foundation in plant biotechnology, biochemistry, and environmental risk analysis, Vasudhevan has published multiple articles in high-impact journals. His work reflects his dedication to addressing critical environmental challenges through innovative research and sustainable solutions.

Publication Profile:

Scopus

Strengths for the Award:

Palanisamy Vasudhevan is a well-rounded researcher with a proven track record of over nine years in the fields of environmental science, biochemistry, and bioremediation. His research focuses on addressing critical global environmental issues, such as chlorinated aromatic contaminant degradation, soil ecology, phytoremediation, heavy metal assessment, and health risk analysis.

His post-doctoral research on organic ligand-assisted Fe(II)-activated persulfate for enhanced degradation of contaminants in soil and water demonstrates innovative approaches to environmental remediation. With multiple high-impact publications in reputable journals like the International Journal of Biological Macromolecules and the Journal of Hazardous Materials Advances, Vasudhevan has contributed significantly to advancing knowledge in biocatalysis and environmental health. Furthermore, his expertise in phytoremediation and cadmium accumulation in rice makes him a leader in applying plant biotechnology for solving soil contamination issues.

His ability to secure fellowships, like the Junior Research Fellowship and University Research Fellowship, shows his leadership potential and commitment to excellence in research.

Areas for Improvement:

While Vasudhevan has an impressive research profile, expanding his research collaborations internationally and diversifying his research themes could further enhance his impact. Engaging in interdisciplinary research with experts in fields like environmental engineering, public health, and policy-making could broaden the scope of his contributions and translate his work into real-world solutions. Additionally, focusing on developing practical, scalable methods for large-scale remediation projects could help bridge the gap between research and implementation.

Education:

Palanisamy Vasudhevan pursued his academic journey with a strong emphasis on environmental science and biochemistry. He is currently a Post-Doctoral Fellow in Geological Engineering at the State Key Laboratory of Geohazard Prevention and Geoenvironment Protection, Chengdu University of Technology, China. He earned his Ph.D. in Environmental Science from Periyar University, India (2014-2022), focusing on cadmium and heavy metal accumulation in paddy soils and rice varieties. Before his doctoral work, he completed his Master’s and Bachelor’s degrees in Biochemistry from K.S. Rangasamy College of Arts & Science, Tamil Nadu, India, where he achieved high academic excellence (82.08% in MSc and 71.5% in BSc). This extensive academic background provides Vasudhevan with a robust understanding of biochemistry, environmental science, and their applications in solving global ecological problems.

Experience:

Palanisamy Vasudhevan’s academic and professional experiences span several research fields, including bioremediation, soil ecology, and heavy metal assessment. As a Post-Doctoral Fellow, he has worked on organic ligand-assisted Fe(II)-activated persulfate for enhanced degradation of chlorinated aromatic contaminants in soil and water, contributing to sustainable environmental cleanup. His doctoral research focused on the accumulation of cadmium and other heavy metals in paddy soils and rice, contributing valuable insights into soil pollution and its impact on food security. Additionally, Vasudhevan has three years of experience as a Junior Research Fellow (JRF) in phytoremediation, studying metal-tolerant plants in industrial clusters. Throughout his career, Vasudhevan has demonstrated leadership, commitment, and an ability to secure research fellowships and grants, strengthening his research profile. His interdisciplinary expertise positions him as a researcher dedicated to solving environmental issues with sustainable, innovative solutions.

Research Focus:

Palanisamy Vasudhevan’s research primarily addresses environmental contamination, focusing on heavy metals, chlorinated aromatic compounds, and the role of phytoremediation in detoxifying polluted ecosystems. His recent work involves enhancing soil and water remediation processes using organic ligand-assisted Fe(II)-activated persulfate, an advanced oxidative technology for degrading persistent pollutants. He also investigates the bioremediation potential of metal-tolerant flora, contributing to sustainable solutions for cleaning up contaminated industrial sites. Vasudhevan’s doctoral research explored cadmium and heavy metal accumulation in agricultural soils, with an emphasis on food safety and ecological risk assessment in rice cultivation. Furthermore, his work in biocatalysis and plant biotechnology explores innovative applications of enzymes for environmental clean-up and waste management. Through his interdisciplinary research, Vasudhevan aims to advance environmental sustainability by mitigating the effects of pollution, improving ecosystem health, and ensuring food security, particularly in contaminated agricultural regions.

Publications Top Notes:

  1. Biocatalytic enzymes in food packaging, biomedical, and biotechnological applications: A comprehensive review 🧬🧪 (2025)
  2. Enhanced biocatalytic laccase production using agricultural waste in solid-state fermentation by Aspergillus oryzae for p-chlorophenol degradation 🌿💡 (2024)
  3. Organic Ligand-Assisted Fe (II)-Activated Persulfate for Enhanced Degradation of Chlorinated Aromatic Contaminants in Soil Remediation 🌍🧪 (2024)
  4. Pollution assessment, ecological risk and source identification of heavy metals in paddy soils and rice grains from Salem, South India 🌾⚖️ (2025)
  5. Uptake and translocation of cadmium and trace metals in common rice varieties at different growth stages 🌱⚙️ (2024)
  6. Pollution assessment and source apportionment of metals in paddy field of Salem, South India 🏞️💧 (2022)

Conclusion:

Palanisamy Vasudhevan is undoubtedly a strong candidate for the Research for Best Researcher Award. His innovative contributions, particularly in environmental remediation and bioremediation, showcase his potential to make lasting impacts on global environmental sustainability. His academic and research achievements highlight his dedication and leadership in the scientific community. With minor enhancements to his collaborative and application-focused work, Vasudhevan could further elevate his role as a leading researcher in environmental sciences.

 

 

 

Ting Wang | Blood brain barrier | Best Researcher Award

Published on by Cell Biologist

Dr. Ting Wang | Blood brain barrier | Best Researcher Award

Dr. Ting Wang , Guangzhou First People’s Hospital , China

Dr. Wang Ting, born on September 16, 1989, is an accomplished attending physician in the Department of Neurology at Guangzhou First People’s Hospital. She earned her Doctor of Medicine degree and actively mentors master’s students specializing in clinical practice. With a robust background in neurology, Dr. Wang has developed expertise in managing Parkinson’s disease, movement disorders, and cognitive disorders. Her innovative research spans across clinical treatments, including deep brain stimulation, botulinum toxin injections for dystonia, and studying intracranial infections. Dr. Wang is an esteemed member of several key medical committees in Guangdong, focusing on neurological diseases and geriatric healthcare. With a passion for improving patient outcomes and advancing research, Dr. Wang has made significant contributions to the field, with multiple publications in high-impact journals.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Wang Ting is highly deserving of the Best Researcher Award due to her significant contributions to the field of neurology. Her extensive expertise in clinical practice and research, particularly related to Parkinson’s disease, movement disorders, cognitive disorders, and deep brain stimulation, places her at the forefront of neurological science. Her work is not only clinically impactful but also academically rigorous, evidenced by multiple high-impact publications in renowned journals. Dr. Wang’s research spans several crucial areas in neurology, including botulinum toxin therapy, brain stimulation, and cognitive disorder treatments. Furthermore, her involvement in prestigious committees and mentorship roles highlights her leadership in the field, as she actively shapes the next generation of neurologists. The depth and breadth of her research, along with her commitment to improving patient outcomes, demonstrate her outstanding qualifications for this award.

Areas for Improvement:

While Dr. Wang’s research is already of the highest caliber, there are always opportunities for growth in a dynamic field like neurology. Expanding her collaborative efforts with international research teams could further enhance the global reach and impact of her work. Additionally, Dr. Wang may benefit from increasing her involvement in interdisciplinary studies, particularly exploring the intersection between neuroscience and other emerging fields like genetics, artificial intelligence, and personalized medicine. Integrating cutting-edge technologies such as AI-driven diagnostics or biomarkers could open new avenues for her research, allowing for deeper insights into the complexities of neurological diseases.

Education:

Dr. Wang Ting completed her Doctor of Medicine (MD) degree, showcasing her commitment to advancing medical knowledge and patient care. As a medical professional, she has continually pursued academic excellence and deepened her clinical expertise, particularly in neurology. Over the years, she has balanced clinical practice with research, helping to guide the future of treatments for movement disorders, cognitive impairments, and neurological diseases. In addition to her medical degree, Dr. Wang is actively involved in the mentorship of master’s students specializing in clinical practice. This role allows her to impart her knowledge, inspire the next generation of neurologists, and encourage academic growth within the medical community. Dr. Wang’s continuous educational development and contributions to her field demonstrate a strong dedication to advancing neurology, particularly in complex areas like Parkinson’s disease and deep brain stimulation.

Experience:

Dr. Wang Ting has a well-rounded career in neurology, having served as an attending physician at Guangzhou First People’s Hospital, one of the leading medical institutions in China. Her role includes diagnosing and treating complex neurological conditions such as Parkinson’s disease, movement disorders, and cognitive impairments. With hands-on expertise in deep brain stimulation and botulinum toxin therapy, Dr. Wang has successfully applied her knowledge in clinical settings, directly impacting patient outcomes. She is also a mentor for master’s students, guiding future neurologists in clinical practice and research. Dr. Wang’s extensive involvement in medical committees, such as the Hypertensive Cerebral Hemorrhage Subcommittee and the Parkinson’s Disease Committee of Guangdong, highlights her leadership in advancing the field of neurology. Additionally, her participation in national and international research projects has further bolstered her experience in both clinical and academic domains.

Research Focus:

Dr. Wang Ting’s research spans a variety of crucial areas in neurology, focusing particularly on Parkinson’s disease, movement disorders, and cognitive impairments. One of her key research areas includes the comprehensive management of Parkinson’s disease, including preoperative screening and postoperative programming for deep brain stimulation. She has conducted significant research on botulinum toxin type A injection therapy for focal dystonia. Dr. Wang is also engaged in understanding the pathophysiology of intracranial infections and cognitive disorders, alongside her work in the basic research of neurological diseases. Her research seeks to develop better therapeutic strategies and diagnostics to improve patient outcomes in these areas. Dr. Wang’s work is further exemplified by her involvement in studying vascular, inflammatory, and metabolic risk factors related to dementia in Parkinson’s disease patients with comorbid type 2 diabetes. Through her research, Dr. Wang aims to bridge the gap between clinical practice and scientific advancements in neurology.

Publications Top Notes:

  1. Disease spectrum and prognostic factors in patients treated for tuberculous meningitis in Shaanxi province, China 🧠🔬
  2. Downregulation of platelet-derived growth factor receptor β in pericytes increases blood-brain barrier permeability and significantly enhances α-synuclein in a Parkinson’s Disease 3D cell model 🧪🧑‍🔬
  3. Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus 💔🧠
  4. High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China 💉🌍
  5. Sub-optimal specificity of modified Ziehl-Neelsen staining for quick identification of tuberculous meningitis 🔬🦠
  6. Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson 🧬⚡
  7. Clinical manifestations and changes in cerebrospinal fluid cytology of patients with meningeal carcinomatosis 🧪💀
  8. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma 🧠🩺
  9. Translation of the headache chapter in the 19th edition of Harrison’s Principles of Internal Medicine 📖👩‍⚕️

Conclusion:

Dr. Wang Ting stands out as an exemplary researcher and clinician in the field of neurology, with a strong track record of groundbreaking research and significant contributions to the understanding and treatment of neurological disorders. Her comprehensive approach to clinical practice, mentorship, and research positions her as an invaluable asset to the field. With her dedication to improving patient care and advancing scientific understanding, Dr. Wang Ting is undoubtedly a strong candidate for the Best Researcher Award.

 

 

 

Huining He | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Huining He | Cancer Cell Biology | Best Researcher Award

Prof. Huining He , School of Biomedical Engineering and Technology, Tianjin Medical University , China

Dr. Huining He is a prominent Professor and the Dean of the School of Biomedical Engineering and Technology at Tianjin Medical University, China. With a Ph.D. in Chemical Engineering from Tianjin University, she completed joint research at the University of Michigan. Her career spans across significant achievements in biomedical engineering, specializing in biomaterials, drug delivery systems, and cancer therapy. She has been recognized with prestigious awards, including the “Young Changjiang Scholar” and the “Tianjin Science Fund for Outstanding Young Scholars.” As an active member of various academic societies and a board member of the Asian Journal of Pharmaceutical Sciences, she fosters international collaboration and academic advancement. Her research has garnered substantial contributions to the field of biomedical engineering, with numerous patents and high-impact publications in cancer treatment and drug delivery systems.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Huining He is an outstanding researcher with a strong academic and professional background. As a Professor and Dean at Tianjin Medical University, she leads the School of Biomedical Engineering and Technology with a focus on cutting-edge biomedical research, particularly in biomaterials and drug delivery systems. Her innovative work in the development of enzyme-sensitive targeted systems for gene therapy and prodrug-type macromolecular drug delivery for colon cancer is a key contribution to the field. Additionally, her leadership in several projects funded by the National Natural Science Foundation of China, particularly those targeting glioma treatment, showcases her ability to translate research into impactful clinical applications.

Dr. He’s collaboration with international and domestic institutions further enhances her research impact. She is well-regarded for pioneering novel drug delivery systems and has made notable contributions through numerous high-quality publications, which have earned her an H-index of 21 and six authorized patents. She also actively participates in academic exchanges and professional networks, serving as a member of editorial boards and scientific committees.

Areas for Improvements:

While Dr. He has made remarkable strides in biomedical engineering, there are areas where further focus could amplify her impact:

  1. Broader Clinical Application: The continued translation of her drug delivery systems into clinical settings could benefit from additional industry partnerships and clinical trials.
  2. Interdisciplinary Collaboration: Expanding her work to incorporate emerging fields such as artificial intelligence in drug delivery systems could lead to more personalized treatment solutions.
  3. Public Engagement: Increasing public awareness of her research through media and outreach could bridge the gap between academia and the general public, facilitating broader societal impact.

Education:

Dr. Huining He earned her Ph.D. in Chemical Engineering from Tianjin University, where she gained profound expertise in biomaterials and drug delivery systems. During her doctoral studies, she participated in joint training at the University of Michigan, an experience that greatly expanded her research skills and international perspective. This training allowed her to engage in cutting-edge projects in the fields of biomaterials and drug delivery. Her advanced education laid the foundation for her future contributions to biomedical engineering, especially in the development of novel targeted systems for gene therapy and cancer treatment. Dr. He’s academic journey has been marked by strong mentorship, international collaborations, and her leadership role in several research projects that have significantly advanced the biomedical field.

Experience:

Dr. Huining He’s career in biomedical engineering spans extensive academic and research experience. Currently, as the Dean of the School of Biomedical Engineering and Technology at Tianjin Medical University, she leads a dynamic department focused on advancing healthcare solutions through innovative research. She has supervised numerous Ph.D. students, guiding them in pioneering research on biomaterials and drug delivery systems. Her work has been recognized by the Ministry of Education, with prestigious titles such as the “Young Changjiang Scholar.” Dr. He has led and contributed to several high-profile research projects funded by China’s National Natural Science Foundation, including investigations into enzyme-sensitive targeted systems for gene therapy and glioma treatment. Beyond academia, she has participated in industry projects, translating her research into real-world applications. As a member of numerous professional organizations and editorial boards, Dr. He plays a vital role in facilitating international collaborations and advancing scientific knowledge in the biomedical sector.

Research Focus:

Dr. Huining He’s research focuses on the design and development of advanced biomaterials and drug delivery systems, particularly in the treatment of cancer and other serious diseases. Her work involves creating innovative, targeted drug delivery systems that can enhance the efficacy and precision of treatment. She has conducted pivotal studies on enzyme-sensitive targeted systems for gene therapy, improving the delivery of therapeutic agents to cancer cells. Currently, Dr. He is leading several projects on siRNA co-delivery systems for glioma, investigating ways to overcome the challenges in glioma treatment. Her research also covers the development of prodrug-type macromolecular systems and multifunctional exosome-based drug delivery technologies. Dr. He’s work has the potential to revolutionize cancer treatment and other therapeutic approaches, contributing to the development of more efficient, less toxic therapies for patients. Her research continues to make substantial advancements in the fields of drug delivery, biomedical engineering, and cancer therapy.

Publications Top Notes:

  1. CaCO3-based nanomedicine with multi-functions of ferroptosis-apoptosis and microenvironment regulation in cancer 🔬💡 (Nano Today, 2025)
  2. Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation 🧬⚡ (ACS Nano, 2024)
  3. Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy 💊🧪 (Chinese Chemical Letters, 2024)
  4. A review on gold nanoparticles as an innovative therapeutic cue in bone tissue engineering: Prospects and future clinical applications 🏥🔬 (Materials Today Bio, 2024)
  5. Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment 🧬🔗 (Journal of Controlled Release, 2024)
  6. An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma 💉🧠 (Acta Pharmaceutica Sinica B, 2023)
  7. Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles 🧬💥 (Acta Pharmaceutica Sinica B, 2023)
  8. Dual-sensitive drug-loaded hydrogel system for local inhibition of post-surgical glioma recurrence 💧⚔ (Journal of Controlled Release, 2022)
  9. Antibody–siRNA conjugates (ARC): Emerging siRNA drug formulation 🧬💉 (Medicine in Drug Discovery, 2022)
  10. mRNA vaccines for COVID-19 and diverse diseases 💉🦠 (Journal of Controlled Release, 2022)

Conclusion:

Dr. Huining He’s exceptional contributions to the field of biomedical engineering, particularly in the development of novel drug delivery systems for cancer treatment, position her as an ideal candidate for the Best Researcher Award. Her innovative work, combined with a clear vision for the future of precision medicine, continues to drive the field forward. She has the potential to further revolutionize medical treatments, making her a deserving nominee for this prestigious recognition.

 

 

 

Yesuneh Tefera Mekasha | Pharmaceutical Sciences | Best Researcher Award

Published on by Cell Biologist

Mr. Yesuneh Tefera Mekasha | Pharmaceutical Sciences | Best Researcher Award

Mr. Yesuneh Tefera Mekasha , University of Gondra , Ethiopia

Yesuneh Tefera Mekasha is a dedicated researcher specializing in pharmaceutical quality assurance, regulatory affairs, and veterinary pharmacy. With extensive experience in drug development, quality control, pharmacovigilance, and policy evaluation, he aims to optimize medication use, particularly in Ethiopia. Holding an MSc in Pharmaceutical Quality Assurance and Regulatory Affairs from Jimma University and a Bachelor’s degree in Veterinary Pharmacy, he has published over 15 research papers and is an active peer reviewer for internationally indexed journals. He is currently an academic research advisor at the University of Gondar, focusing on pharmaceutical education, research, and quality assurance. Yesuneh’s work has earned him multiple awards, including a gold medal for academic excellence from the University of Gondar and recognition for his contributions to research and quality control testing.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Academic and Professional Background:
    Yesuneh Tefera Mekasha demonstrates an exceptional academic background with a Master of Science (MSc) in Pharmaceutical Quality Assurance and Regulatory Affairs, and a Bachelor’s degree in Veterinary Pharmacy. The researcher’s qualifications, including certificates in various pharmaceutical and quality assurance-related fields, highlight their commitment to professional growth.
  2. Prolific Research Output:
    Yesuneh has made significant contributions to the field with over 15 published articles, many of which focus on pharmaceutical quality, regulatory affairs, and the pharmacovigilance landscape in East Africa. Their research contributions are substantial and cover important issues, such as the interchangeability of drug brands, quality control testing, antimicrobial resistance, and herbal medicine legislation.
  3. Leadership and Mentorship:
    The researcher has demonstrated leadership and a commitment to education through their roles as a lecturer, academic research advisor, and mentor. They have actively contributed to shaping the future generation of researchers and professionals in the pharmaceutical field, particularly by guiding students in their research and providing expertise in quality assurance.
  4. Research Focus on Public Health Issues:
    Yesuneh’s research is highly relevant to public health, especially in the context of improving the quality and safety of medicines in Ethiopia. They have examined the quality evaluation of commonly marketed pharmaceutical products, such as Azithromycin, and assessed issues such as counterfeit drugs and antimicrobial resistance, which are significant challenges in the Ethiopian healthcare system.
  5. Strong Analytical Skills:
    The researcher has a solid understanding of advanced analytical methods, such as HPLC, dissolution profile comparison, and the use of KinetDS software for pharmacokinetic modeling. This expertise is crucial for ensuring the effectiveness and safety of pharmaceutical products.
  6. Awards and Recognition:
    Yesuneh has received multiple honors, including a gold medal from the University of Gondar and recognition for the best MSc thesis. Their work has been consistently recognized by peers, underscoring their impact in the field.
  7. International Collaboration and Peer Review Involvement:
    The researcher is involved in peer review for several internationally indexed journals and has collaborated with various academic institutions and pharmaceutical entities, highlighting their recognition in the global research community.

Areas for Improvement:

  1. Wider Global Impact:
    While Yesuneh has made notable contributions within Ethiopia and East Africa, expanding the scope of their research to broader global contexts could strengthen their influence. Collaborations with international pharmaceutical bodies or larger-scale studies that address global drug safety and quality would enhance their international profile.
  2. Diversification of Research Focus:
    Yesuneh’s research has primarily focused on pharmaceutical quality assurance and regulatory affairs. Expanding research interests into other areas within pharmacy, such as drug discovery or clinical pharmacology, could provide a more well-rounded expertise.
  3. Increased Public Outreach:
    Although Yesuneh’s contributions to academic journals and teaching are commendable, engaging in more public outreach to communicate the importance of their research could have a greater societal impact. Hosting workshops, webinars, or community-driven research initiatives could promote greater public awareness of pharmaceutical quality issues.

Education:

Yesuneh Tefera Mekasha completed his MSc in Pharmaceutical Quality Assurance and Regulatory Affairs from the University of Jimma in 2022, achieving a GPA of 3.91 out of 4.00. His thesis, “Quality evaluation of Azithromycin tablets,” earned an excellent grade. He also holds a Bachelor’s degree in Veterinary Pharmacy from the University of Gondar (2018), where he achieved a GPA of 3.84 out of 4.00. Additionally, he has completed a Higher Diploma in Teaching Methodology and various certifications in health economics, chemical assessment, pharmaceutical quality assurance, and tropical dermatology. Yesuneh’s solid academic foundation is complemented by his ongoing professional development, including specialized training in pharmaceutical systems and supply chain management from organizations like WHO and USAID.

Experience:

Yesuneh Tefera Mekasha’s career spans across academic, research, and industrial settings. He currently serves as an academic research advisor and faculty member at the University of Gondar, teaching courses in pharmaceutical analysis, pharmacoepidemiology, and supply chain management. He is also involved in postgraduate research and quality assurance projects, collaborating with Jimma University’s pharmaceutical quality assurance team. His previous experience includes quality control analysis at the Ethiopian Pharmaceutical Manufacturing Company, where he developed standard operating procedures and tested pharmaceutical products for compliance with quality standards. Yesuneh has also worked on several research projects addressing drug quality issues in Ethiopia, particularly focusing on antimicrobial resistance and substandard medicines, and has been part of multiple international conferences and training programs.

Awards and Honors:

Yesuneh Tefera Mekasha has received multiple prestigious awards throughout his academic and professional career. In 2018, he was honored with a gold medal by the University of Gondar for being the top student in his class. He also earned recognition from an Ethiopian pharmaceutical company for his contributions to quality control testing during his postgraduate studies. Furthermore, Yesuneh received certificates of excellence for his involvement in research, including the “Outstanding Student Award” at the University of Jimma in 2019 for his excellent thesis on azithromycin quality evaluation. His continued success is marked by awards from global organizations, such as the People’s Republic of China for completing a short-term training program on social governance and capacity building.

Research Focus:

Yesuneh Tefera Mekasha’s research primarily focuses on pharmaceutical quality assurance, regulatory affairs, pharmacovigilance, and antimicrobial stewardship. His work aims to address the challenges of substandard pharmaceutical products in Ethiopia, with a particular emphasis on drug dissolution profiles and interchangeability in clinical practice. In his MSc thesis, Yesuneh evaluated the quality of Azithromycin tablets and modeled their dissolution profiles to determine clinical interchangeability. He is also committed to improving pharmaceutical policies and practices, with a specific focus on the regulation of veterinary medicines and antimicrobial resistance. Yesuneh’s research has been widely published and seeks to influence both local and global practices in pharmaceutical quality control and regulation.

Publications Top Notes:

  1. Validation of an ultraviolate-visible spectrophotometric method for determination of fenbendazole in tablet dosage form 🧪
  2. Traditional Herbal Medicine Legislative and Regulatory framework: A cross-sectional quantitative study 🌿
  3. A narrative review of veterinary pharmacovigilance situations and prospects in East African countries 🐾
  4. Evaluation of the Knowledge, Attitudes and Practice of Veterinary Professionals Regarding Antimicrobial Use 💉
  5. A Narrative Review on Medicine Quality, Regulatory System, and Quality by Design 📊
  6. Modeling and comparison of dissolution profiles for different brands of albendazole boluses 💊
  7. Quality evaluation of selected expired fluoroquinolones medicines obtained from hospitals in Jimma 🏥
  8. Assessment of veterinary pharmaceutical warehouse management practices in Ethiopia 📦
  9. Evaluating the Knowledge and Regulatory Situation of Veterinary Experts Regarding Counterfeit Veterinary Medications 🚫
  10. Dissolution profile evaluation of selected brands of amoxicillin-clavulanate potassium tablets 💉

Conclusion:

Yesuneh Tefera Mekasha has demonstrated outstanding academic achievements, a strong commitment to research, and significant contributions to the improvement of pharmaceutical practices in Ethiopia. Their work in pharmaceutical quality assurance and regulatory affairs has directly impacted public health and pharmaceutical policy, particularly through research on drug safety, quality control, and antimicrobial resistance.

Their leadership and mentorship have also been vital in fostering future generations of professionals in the field, contributing not only to academic growth but also to the advancement of the pharmaceutical industry in Ethiopia and beyond. Yesuneh’s qualifications, research productivity, and dedication to public health make them an excellent candidate for the Best Researcher Award. With minor improvements in global engagement and research diversification, they have the potential to further elevate their contributions to the field.

 

 

 

Paola Zagami | Cancer Cell Biology | Young Scientist Award

Published on by Cell Biologist

Dr. Paola Zagami | Cancer Cell Biology | Young Scientist Award

Dr. Paola Zagami , IEO european institute of oncology University of Milan , Italy

Dr. Paola Zagami is an accomplished Italian physician and medical oncologist currently working at the European Institute of Oncology (IEO) in Milan. She specializes in clinical and research oncology, focusing on breast cancer. With a strong academic background and passion for advancing cancer treatment, Dr. Zagami has contributed to numerous studies on innovative therapies, particularly immunotherapy and endocrine treatments in breast cancer. She is recognized for her expertise in cancer genomics and the impact of immune checkpoint inhibitors in cancer treatment. Dr. Zagami’s work reflects a blend of clinical practice and research, as she actively collaborates with experts in the oncology field to improve patient outcomes.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Paola Zagami is an exceptional candidate for the Research for Young Scientist Award due to her profound contributions to oncology research, particularly in breast cancer treatment and clinical trials. Her work on immune checkpoint inhibitors, endocrine therapies, and the genomics of breast cancer demonstrates her expertise in precision oncology. Dr. Zagami has been involved in high-impact publications and collaborative international studies, such as her work on metastatic triple-negative breast cancer and the development of novel cancer therapies. Her clinical and research skills, combined with her ability to contribute to the scientific community through publications and awards, make her a highly qualified and promising young scientist. Furthermore, her commitment to gender equity in pharmacological research and clinical trials aligns with the future direction of oncology research, making her a strong contender for the award.

Areas for Improvement:

While Dr. Zagami has made significant strides in breast cancer research, there are opportunities to broaden her research focus to include other cancer types, enabling her to contribute to a wider array of oncological studies. Additionally, further involvement in leading large-scale clinical trials could enhance her leadership in the field. Expanding her research network internationally could facilitate more diverse collaborations and broader research impact.

Education:

Dr. Zagami earned her medical degree (MD) and has since pursued extensive education in the field of oncology. In 2021, she received a scholarship from the IEO-Monzino Foundation, focusing on clinical research in oncology. She further honed her expertise by earning the AMMI award in 2023 for her work on gender equity in pharmacological research. This education in clinical research positions Dr. Zagami as a thought leader in her field, with a commitment to investigating new treatments and approaches in cancer care.

Experience:

Dr. Zagami’s professional career began as an oncological clinical researcher, where she focused on the development of targeted therapies and the clinical impact of cancer treatments. Since 2024, she has been serving as a medical oncologist at the European Institute of Oncology (IEO) in Milan, contributing to both clinical and research activities. Throughout her career, Dr. Zagami has gained experience in advanced oncology treatments, particularly in immunotherapy and endocrine therapies for breast cancer. She works closely with interdisciplinary teams to design and conduct clinical trials, improving personalized cancer care. Dr. Zagami’s research collaborations have resulted in several publications in prestigious journals, reflecting her expertise and commitment to enhancing cancer treatment strategies.

Experience:

Dr. Zagami’s professional career began as an oncological clinical researcher, where she focused on the development of targeted therapies and the clinical impact of cancer treatments. Since 2024, she has been serving as a medical oncologist at the European Institute of Oncology (IEO) in Milan, contributing to both clinical and research activities. Throughout her career, Dr. Zagami has gained experience in advanced oncology treatments, particularly in immunotherapy and endocrine therapies for breast cancer. She works closely with interdisciplinary teams to design and conduct clinical trials, improving personalized cancer care. Dr. Zagami’s research collaborations have resulted in several publications in prestigious journals, reflecting her expertise and commitment to enhancing cancer treatment strategies.

Research Focus:

Dr. Zagami’s research focus is primarily centered around the treatment of breast cancer, particularly in the areas of immunotherapy, endocrine therapy, and personalized medicine. She has been involved in research on immune checkpoint inhibitors for metastatic triple-negative breast cancer and the clinical implications of genomic alterations in breast cancer. Dr. Zagami is also dedicated to investigating the safety and efficacy of novel cancer therapies, particularly in early-phase clinical trials. Her research interests also include the study of gender equity in pharmacological research and the integration of molecular diagnostics in clinical trials for metastatic breast cancer. She is committed to advancing precision oncology by studying the genetic and clinical landscape of breast cancer to enhance patient outcomes and treatment strategies.

Publications Top Notes:

  1. Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?
  2. Triple negative breast cancer: pitfalls and progress.
  3. Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer.
  4. Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives.
  5. Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.
  6. Immunotherapy for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.

Conclusion:

Dr. Paola Zagami is undoubtedly a rising star in the field of oncology. Her combination of clinical experience, research accomplishments, and passion for improving cancer treatments positions her as a highly deserving candidate for the Research for Young Scientist Award. As she continues to advance her work in oncology, her future contributions have the potential to significantly impact cancer care and research globally. With some further expansion in her research focus and leadership roles, Dr. Zagami is poised to be an influential figure in oncology for years to come.

 

 

 

Vidhant Nambiar | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Vidhant Nambiar | Cancer Cell Biology | Best Researcher Award

Dr. Vidhant Nambiar , Fiji National University , Fiji

Dr. [Name] is currently the Acting Head of the Department of Dental Public Health, Paediatrics, and Preventive Dentistry at Fiji National University (FNU). With expertise in public health and dental care, Dr. [Name] is dedicated to improving oral health and public health across Fiji and the Pacific region. Actively involved in academic and clinical research, Dr. [Name] is the Chair of the FNU School of Dentistry and Oral Health’s Research Committee and a member of the Oral Health Pacific Island Alliance (OPIA) and the International Association of Dental Research (IADR). In addition to teaching undergraduate and postgraduate dental students, Dr. [Name] supervises research in areas like oral cancer and the effects of heat-treated cooking oils. A committed researcher and educator, Dr. [Name] also contributes to global oral health advocacy through international collaborations and presentations.

Publication Profile:

Orcid

Strengths for the Award:

  1. Innovative Research Focus: The study “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji” addresses a critical gap in oral health research, specifically the link between environmental carcinogens and oral cancer, an issue of high relevance in Fiji and the broader Pacific region.
  2. Strong Academic Foundation: The researcher holds a Master of Science in Public Health and a Bachelor of Dental Surgery with notable academic achievements. Their award-winning background and practical clinical experience underscore their ability to handle complex research.
  3. Ongoing, High-Impact Research: The study is in a randomized controlled trial phase, demonstrating rigor and potential for publication in high-impact journals. The trial also received seed funding, which reflects its importance to the broader public health community.
  4. Multidisciplinary Expertise: The researcher brings a blend of public health, clinical dentistry, and research skills to the project, offering a holistic approach to understanding health risks in the Pacific Island context.

Areas for Improvements:

  1. Expanded Collaboration: To maximize the impact of the research, future work could involve more international collaborations or partnerships with other universities or research institutes, enhancing the study’s global reach and significance.
  2. Greater Focus on Data Analysis: While the research is promising, further attention to advanced statistical analyses and more diverse data sources could provide even more robust conclusions.
  3. Wider Community Engagement: Increasing community-based research engagement and ensuring that findings are shared with local populations in accessible formats could further strengthen public health responses.

Education:

Dr. [Name] holds a Master of Science in Public Health from the University of South Wales (2021), equipping them with advanced knowledge of public health principles and practices. Prior to that, Dr. [Name] earned a Bachelor of Dental Surgery from Fiji National University (FNU), where they received the prestigious Pierre Fauchard Award in 2017. During their academic journey, Dr. [Name] gained extensive hands-on clinical experience and was exposed to cutting-edge dental technology and modern practices, including through an elective project at Melbourne and La Trobe University in 2017. This solid academic background, paired with practical dental experience, laid the foundation for their commitment to advancing oral health education, research, and policy development.

Experience:

Dr. [Name] has an extensive career in dental public health and clinical practice. As the Acting Head of the Department of Dental Public Health, Paediatrics, and Preventive Dentistry at FNU, Dr. [Name] oversees curriculum development, academic program delivery, and research activities. They have led multiple community outreach initiatives and have a demonstrated ability to manage strategic planning and research projects. Dr. [Name] has also served as a Lecturer in Dental Public Health, teaching courses across various undergraduate levels and guiding students in their research endeavors. Previous roles include managing the oral surgery clinic at CWM Hospital, where they treated complex surgical cases and participated in surgical audits. Dr. [Name] has also been integral in the COVID-19 response efforts, providing support at the Valelevu Fever Clinic and contributing to public health initiatives aimed at controlling the pandemic.

Research Focus:

Dr. [Name]’s research primarily focuses on oral health and public health, with a particular emphasis on the impact of environmental factors on oral health. Currently, they are conducting a randomized controlled trial titled “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji,” which has qualified for seed funding and is pending publication. This research aims to examine the links between oral cancer and the consumption of oils that have been repeatedly heated, a pressing issue in Pacific Island communities. Dr. [Name] is also a supervisor for research projects related to dental technology, community dentistry, and oral health prevention. Additionally, they have contributed to research on tobacco and betel nut chewing habits, publishing findings in the International Journal of Advanced Research. Their research not only aims to improve clinical practice but also has a broader public health impact, focusing on improving prevention strategies and health outcomes.

Publication Top Notes:

  • “Tobacco and Betel Nut Chewing Habits Amongst Fijians of Indian Descent Living in Suva, Fiji” 📚
  • “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji” 🔬

Conclusion:

This researcher demonstrates strong potential for the Best Researcher Award due to their innovative approach to a significant public health issue. Their current research on genotoxic carcinogens in heated cooking oils addresses an underexplored area of oral cancer prevention and risk factors, particularly in Fiji. With a solid academic background and practical experience, the researcher is well-positioned to make significant contributions to the field. Expanding collaborations, enhancing data analysis, and engaging more directly with communities could further amplify the impact of their work.

 

 

 

 

Gonca Çelik | Developmental Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Gonca Çelik | Developmental Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Gonca Çelik , Karadeniz Technical University , Turkey

Assoc. Prof. Dr. Gonca Çelik, born on April 18, 1984, is a distinguished academic with an extensive background in chemistry, particularly in organic chemistry. She earned her bachelor’s degree in Chemistry Teaching from Karadeniz Technical University (KTU) in 2008. Later, she pursued a doctorate in Chemistry, specializing in Organic Chemistry, from KTU, completing her Ph.D. in 2017. With an h-index of 12, she has made significant contributions to scientific research, including 38 publications in SCI-Expanded indexed journals. Dr. Çelik is also recognized for her involvement in various research projects, particularly in enzyme inhibition, molecular docking studies, and the synthesis of bioactive compounds. Fluent in both Turkish and English, she actively collaborates internationally and has authored several impactful publications related to drug development and the synthesis of biologically active compounds, contributing to fields such as medicinal chemistry and biochemistry.

Publication Profile:

Scopus

Strengths for the Award:

Assoc. Prof. Dr. Gonca Çelik is a highly accomplished researcher with a strong background in organic chemistry, particularly in drug development and biological evaluations. Her significant contributions to the field are reflected in her 38 publications in SCI-Expanded indexed journals. She has demonstrated expertise in synthesizing bioactive compounds, investigating their biological activities, and applying molecular modeling techniques, including molecular docking and ADMET studies. Her work on the synthesis of flavonol derivatives, which are potential inhibitors of SARS-CoV-2, underscores her impact on global health research. Dr. Çelik has also been an active participant in multiple national and international research projects, including Tubitak-funded projects, focusing on enzyme inhibition and molecular modeling for disease treatment. Her leadership in scientific research, combined with a solid academic background, positions her as a valuable contributor to scientific advancements.

Areas for Improvement:

While Dr. Çelik’s research is impressive, there is room for greater visibility and dissemination of her findings to broader interdisciplinary audiences. Increased collaboration with researchers from other scientific fields, such as pharmacology and clinical medicine, could enhance the real-world application of her work, particularly in the development of drug therapies. Expanding her research focus to include more clinical trials or translational research could help bridge the gap between laboratory findings and practical medical applications. Additionally, increasing her involvement in scientific outreach or mentorship programs could further contribute to the development of the next generation of researchers in chemistry and pharmacology.

Education:

Dr. Gonca Çelik’s educational journey began with a Bachelor’s degree in Chemistry Teaching from Karadeniz Technical University (KTU) in 2008. She then pursued postgraduate studies, enrolling directly in the doctoral program in Chemistry at KTU, where she specialized in Organic Chemistry, completing her Ph.D. in 2017. Her doctoral research focused on developing bioactive organic compounds with potential therapeutic applications. Dr. Çelik has also gained international exposure during her Master’s studies, spending time at Clausthal University of Technology in Germany in 2014, which broadened her academic perspective and research experience. Over the years, her educational background and research expertise have provided a solid foundation for her ongoing contributions to the field of organic chemistry, particularly in medicinal chemistry, enzyme inhibition, and molecular docking studies. This strong academic base supports her continued success as an academic and researcher in the field of chemistry.

Experience:

Dr. Gonca Çelik’s academic and professional journey spans over a decade. She began her career as a Research Assistant at Karadeniz Technical University (KTU) in 2010, where she worked until 2017. During her time at KTU, she contributed to several research projects in the field of chemistry, including organic synthesis and biological evaluation of compounds. Her academic work has led her to publish multiple papers in international and national journals. In 2014, she expanded her research horizons by spending time as a Master Student at Clausthal University of Technology in Germany, further strengthening her academic profile. Dr. Çelik has also been involved in various Tubitak and KTU-supported research projects, particularly focusing on enzyme inhibition, molecular docking, and bioactive compound synthesis. She has held roles in multiple projects, such as the synthesis of flavonol derivatives for drug development and the study of antimicrobial and anticancer properties of organic compounds.

Research Focus:

Dr. Gonca Çelik’s primary research interests lie in the field of organic chemistry, with a particular focus on bioactive compound synthesis, enzyme inhibition, and molecular docking studies. Her research aims to discover and develop novel organic molecules with potential therapeutic applications, especially in drug development for diseases such as COVID-19. She has worked extensively on synthesizing flavonol derivatives and other bioactive compounds, investigating their enzyme inhibition efficiencies and biological activities. Dr. Çelik’s work in molecular modeling and computational studies (e.g., ADMET and molecular docking) complements her experimental research, helping to predict the behavior of synthesized compounds at the molecular level. Her research has contributed to the development of potential inhibitors for viruses and other diseases, highlighting her interdisciplinary approach that bridges chemistry and pharmacology. She has been involved in several national and international projects, contributing to the scientific community through her publications and innovative research efforts.

Publications Top Notes:

  1. Synthesis, Biological Evaluation and Molecular Docking Studies of Flavonol-3-O-β-D-glycoside as a Potential Inhibitor of SARS-CoV-2 Main Protease (3CLpro) in Drug Development for COVID-19 🧬💊
  2. Synthesis, structural, spectroscopic (NMR, FT-IR and UV–Vis), NLO, in silico (ADMET and molecular docking) and DFT investigations of a flavonol derivative 2-(4-chlorophenyl)-7-fluoro-3-hydroxy-4H-chromen-4-one 🧪🔬
  3. Antimicrobial, cytotoxic, antiviral effects, and spectroscopic characterization of metabolites produced by fusarium oxysporum yp9b 🦠💉
  4. Biological activity, and volatile and phenolic compounds from five Lamiaceae species 🌱🧴
  5. Synthesis, spectroscopic, and photophysicochemical behavior of Zn(II) and Mg(II) phthalocyanine–chalcone conjugates ⚙️🧑‍🔬
  6. New chalcone-3-O-glycoside derivatives: Synthesis and characterization 🧪🔬
  7. Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases 🧫💥

Conclusion:

Dr. Gonca Çelik’s academic achievements, extensive publication record, and leadership in research make her a strong contender for the Best Researcher Award. Her work has made substantial contributions to drug development, specifically in the context of COVID-19 treatment, enzyme inhibition, and molecular modeling. With a solid foundation in chemistry and a forward-looking approach to interdisciplinary research, she continues to push the boundaries of scientific knowledge. Enhancing her outreach efforts and fostering collaborations with clinical researchers will further amplify the impact of her work on global health. Therefore, Dr. Çelik’s research excellence, combined with her potential for future advancements, makes her a deserving candidate for the Best Researcher Award.

 

 

 

Sunita Pokhrel Bhattarai | Signal Transduction Mechanisms | Women Researcher Award

Published on by Cell Biologist

MS. Sunita Pokhrel Bhattarai | Signal Transduction Mechanisms | Women Researcher Award

Ms. Sunita Pokhrel Bhattarai  , Ohio State University , United States

Sunita Pokhrel Bhattarai, PhD, RN, is an accomplished cardiovascular nurse researcher currently pursuing a doctorate at the University of Rochester, New York. Her research focuses on improving the estimation of Left Ventricular Ejection Fraction using ECGs in acute heart failure patients. With a background in emergency and critical care nursing from multiple international institutions, she is committed to advancing healthcare quality, particularly in heart failure care. Dr. Pokhrel Bhattarai’s work is widely published, showcasing expertise in clinical trials, big data analysis, and electrocardiographic assessments in heart failure. She has also contributed significantly to nursing education as a lecturer at Purbanchal University, Nepal. Passionate about reducing healthcare discrepancies, she actively participates in academic and clinical research collaborations, making significant strides in her field.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Sunita Pokhrel Bhattarai is an exceptional researcher with a clear commitment to advancing cardiovascular nursing and improving healthcare outcomes for acute heart failure patients. Her research on estimating Left Ventricular Ejection Fraction using ECGs demonstrates innovation and clinical relevance. Her ability to bridge clinical practice with advanced research methodologies, including big data analysis and electrocardiographic assessment, sets her apart. Moreover, her international academic background and diverse professional experience in countries like Nepal, Spain, and the United States highlight her versatility and ability to contribute globally to healthcare solutions. Dr. Pokhrel Bhattarai’s consistent publication record in top-tier journals and her involvement in prestigious research projects further underscores her dedication to advancing nursing knowledge.

Areas for Improvement:

While Dr. Pokhrel Bhattarai has an outstanding academic and research profile, expanding her research to explore broader healthcare disparities, particularly in rural or underserved populations, could enhance the impact of her work. Additionally, pursuing interdisciplinary collaborations with engineers, statisticians, and other healthcare professionals could provide opportunities for more cutting-edge innovations, particularly in ECG-based diagnostic technology and AI integration.

Education:

Dr. Sunita Pokhrel Bhattarai has an extensive academic background. She is currently pursuing a PhD in Health Science and Nursing at the University of Rochester (2020-2024), under the mentorship of Dr. Mary G Carey. Her research explores estimating Left Ventricular Ejection Fraction using ECGs for acute heart failure patients. Dr. Pokhrel Bhattarai earned her MS in Nursing (2015-2017), specializing in Emergency and Critical Care Nursing, from institutions across Spain, Portugal, and Finland. Her research during this time focused on Advanced Cardiac Life Support knowledge among critical care nurses. She completed her BS in Nursing in 2012 from Maharajgunj Nursing Campus, Nepal, with a focus on Community Health Nursing. Throughout her academic career, she has demonstrated a commitment to advancing nursing knowledge and improving healthcare outcomes in cardiovascular care.

Experience:

Dr. Sunita Pokhrel Bhattarai has diverse professional experience across multiple countries. She has worked as a Nursing Lecturer at Purbanchal University in Kathmandu, Nepal (2017-2020), where she educated future nurses in critical care and advanced cardiovascular practices. As a registered nurse at Shahid Gangalal National Heart Centre, Kathmandu, Nepal (2009-2015), she gained hands-on experience in cardiovascular care, particularly in heart failure management. Additionally, she has been involved in research coordination and manuscript review, demonstrating expertise in big data analysis and clinical trials. Dr. Pokhrel Bhattarai has also held positions as a Research Lead Coordinator and Associate, collaborating with international researchers and contributing to advancing healthcare outcomes, particularly in cardiovascular nursing.

Awards and Honors:

Dr. Sunita Pokhrel Bhattarai has received numerous prestigious awards, highlighting her excellence in research and commitment to healthcare. In 2023, she was awarded the Travel Grant by the Council on Cardiovascular and Stroke Nursing Early Career, American Heart Association, and received the Presidential Stronger as One Diversity Award from the University of Rochester. She also secured a research grant from the International Society for Computerized Electrocardiology Conference. Dr. Pokhrel Bhattarai’s accomplishments include the Ireta Neumann Scholarship for International Nurses, providing $5,000 to support her research endeavors. These awards emphasize her leadership and contributions to cardiovascular nursing, both academically and clinically.

Research Focus:

Dr. Sunita Pokhrel Bhattarai’s research focus lies in the intersection of acute heart failure, ECG technology, and cardiovascular nursing. Her PhD dissertation explores estimating Left Ventricular Ejection Fraction using ECGs, aiming to provide accurate, non-invasive diagnostic tools for acute heart failure. She is passionate about identifying self-care strategies for heart failure patients and improving healthcare implementation strategies. Additionally, her work involves big data analysis, electrocardiographic assessment, and clinical trials to better understand heart failure progression and outcomes. Dr. Pokhrel Bhattarai is dedicated to addressing healthcare discrepancies, particularly in global cardiovascular health, and advancing evidence-based nursing practices through innovative research.

Publications Top Notes:

  1. Association Between Increased Serum Albumin and the Length of Hospital Stay among Acute Heart Failure 🏥
  2. Delays in Door-to-Diuretic Time and 1-Year Mortality among Patients with Heart Failure ⏳❤️
  3. Signs and Symptoms Clusters Among Patients With Acute Heart Failure 🔍💓
  4. Integrative Review of Electrocardiographic Characteristics in Patients with Reduced, Mildly Reduced, and Preserved Heart Failure 📊📈
  5. Knowledge and Practices on Prevention of Coronary Artery Diseases in Nepalese Community 🇳🇵💓
  6. Estimating Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure 💖📉
  7. Door-to-Diuretic Time is Related to Length of Hospital Stay Independent of Diuretic Dose ⏰💊
  8. Estimating Very Low Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure ❤️📉
  9. Association Between Serum Albumin and the Length of Hospital Stay Among Patients With Acute Heart Failure 🧑‍⚕️⏱
  10. Estimating Ejection Fraction from the 12 Lead ECG in Acute Heart Failure 💓📝

Conclusion:

Dr. Sunita Pokhrel Bhattarai’s combination of innovative cardiovascular research, global nursing expertise, and dedication to improving patient outcomes makes her an excellent candidate for the Research for Best Researcher Award. Her strong track record in research, awards, and contributions to cardiovascular nursing makes her deserving of this recognition, and her future endeavors hold great potential to further elevate the field of health science and nursing.

 

 

 

Aruto Takano | Parasitology | Best Researcher Award

Published on by Cell Biologist

Dr. Aruto Takano | Parasitology | Best Researcher Award

Dr. Aruto Takano , Osaka Metropolitan University , Japan

Aruto Takano is a dedicated PhD student, clinical veterinarian, and consultant in the poultry industry. Currently pursuing his doctorate at Osaka Metropolitan University, he specializes in the health management and disease control of chickens and ducks. His expertise spans across countries such as Japan, China, the Philippines, and Indonesia, where he provides on-field consultations to improve farm productivity and animal welfare. Takano’s work integrates hands-on veterinary care with scientific research, focusing on pathogens, disease prevention, and sustainable farming practices. His contributions to poultry health are backed by his commitment to practical, data-driven solutions. Through workshops, training, and scientific publications, Takano’s research and fieldwork significantly impact veterinary practices globally, enhancing both animal welfare and farming efficiency.

Publication Profile:

Orcid

Strengths for the Award:

Aruto Takano demonstrates significant strengths in both his clinical and research roles within the poultry industry. His expertise in disease control and health management for chickens and ducks, combined with his global consulting experience in countries such as Japan, China, the Philippines, and Indonesia, showcases his broad impact on sustainable farming practices. Takano’s molecular research on Eimeria, specifically developing simplified protocols for PCR template preparation, highlights his innovative approach to overcoming challenges in parasitology. His publications in peer-reviewed journals, such as Vet Med Sci and Acta Parasitol, contribute valuable knowledge to the veterinary community and support advancements in poultry health management.

Areas for Improvement:

While Takano has made substantial contributions, there are opportunities to expand his collaborative efforts and engage with a broader range of international researchers. Enhancing interdisciplinary collaborations may further strengthen the impact of his work, particularly in areas like farm management and biosecurity.

Education:

Aruto Takano is currently a PhD student at Osaka Metropolitan University, within the Graduate School of Veterinary Science. His education began with a veterinary degree, followed by specialization in veterinary science. During his academic journey, Takano has developed expertise in parasitology, particularly the molecular analysis of Eimeria species, and has contributed significantly to improving poultry health management. His doctoral research aims to address key challenges in poultry farming, such as disease control and pathogen detection. Takano has studied in multiple international environments, including China, the Philippines, and Indonesia, which has further enriched his understanding of global poultry health challenges. His comprehensive approach to both clinical and research aspects positions him as a skilled professional in his field. His work bridges the gap between academic research and practical solutions for poultry farming, enhancing sustainable farming practices and animal welfare.

Experience:

Aruto Takano’s professional experience spans several countries, including Japan, China, the Philippines, and Indonesia, where he has served as a clinical veterinarian and poultry industry consultant. His expertise primarily focuses on chickens and ducks, providing disease control and productivity improvement solutions for farms. Takano combines fieldwork with scientific research, collecting data to develop effective disease prevention strategies and improve animal welfare. His consulting services extend to 15 poultry farms, where he has provided advice on health management and productivity optimization. In addition to his practical work, he conducts molecular research on pathogens like Eimeria, aiming to refine diagnostic and prevention techniques. His collaboration with farmers and researchers in diverse farming environments gives him a deep understanding of both regional challenges and universal concerns in the poultry industry. His holistic approach and commitment to animal welfare make him a recognized expert in veterinary science and poultry health management.

Research Focus:

Aruto Takano’s research primarily focuses on parasitology and veterinary medicine, particularly addressing the challenges posed by Eimeria, a genus of protozoan parasites responsible for coccidiosis in poultry. His work revolves around developing more effective methods for detecting and controlling Eimeria, which is known for its resistance to environmental conditions and its role in causing gastrointestinal diseases in chickens and ducks. Takano’s research includes the molecular analysis of Eimeria, exploring efficient DNA extraction techniques from the tough oocyst walls to improve epidemiological data accuracy. His recent innovations include a simplified PCR template preparation method, which does not require specialized reagents, making it accessible for widespread use. Takano’s contributions are vital for improving disease control in the poultry industry, as his work helps prevent the spread of coccidiosis and ensures better health management practices in diverse farming environments. His efforts contribute to both animal welfare and sustainable poultry farming practices globally.

Publications Top Notes:

  1. Evaluation of the detection method by a flotation method using a wire loop for gastrointestinal parasites – Vet Med Sci (2024) 🦠
  2. Detection of Eimeria oocysts in chicken feces using flotation recovery with sucrose or saturated saline solution – Acta Parasitol (2025) 🐔
  3. An ultra-simplified protocol for PCR template preparation from both unsporulated and sporulated Eimeria oocysts – Poult Sci (Accepted) 🔬

Conclusion:

Aruto Takano is highly deserving of the Best Researcher Award due to his significant contributions to both veterinary medicine and the poultry industry. His research on Eimeria and dedication to improving poultry health management globally highlight his potential for continued impact on animal welfare and farm sustainability. Takano’s innovative methods and hands-on approach to solving real-world problems make him a standout candidate for this prestigious award.

 

 

 

 

Priya Samalia | Cellular Senescence Aging | Best Researcher Award

Published on by Cell Biologist

Dr. Priya Samalia | Cellular Senescence Aging | Best Researcher Award

Dr. Priya Samalia , Health New Zealand , New Zealand

Dr. Priya Samalia is a dedicated Ophthalmologist, specializing in retinal diseases, uveitis, and cataract surgery. With extensive experience in both clinical and academic settings, Dr. Samalia combines her expertise in patient care with a commitment to advancing the field of ophthalmology through research. She holds an MBChB, a Postgraduate Diploma in Ophthalmic Basic Sciences, and a PhD from the University of Otago. Her strong communication skills foster a supportive environment for patients, ensuring high levels of satisfaction and well-being. Dr. Samalia is a Fellow of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO) and has held roles across various health organizations in New Zealand, where she focuses on improving patient outcomes in complex eye conditions. As a clinical senior lecturer, she also contributes to the training of future ophthalmologists at the University of Otago.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Priya Samalia demonstrates exceptional contributions to the field of ophthalmology, particularly in uveitis, retinal diseases, and cataract surgery. Her academic and clinical expertise is evident through her extensive work in diagnosing and managing complex ocular conditions. Dr. Samalia’s research is published in prestigious journals, including British Journal of Ophthalmology and Clinical and Experimental Ophthalmology. Her multi-disciplinary approach to managing ocular diseases through systemic treatments and her involvement in international studies further establishes her as a leader in her field. As a Clinical Senior Lecturer at the University of Otago, Dr. Samalia actively contributes to the training and mentorship of future ophthalmologists, further demonstrating her commitment to knowledge transfer.

Areas for Improvement:

While Dr. Samalia’s research focus is impressive, expanding her influence through larger-scale clinical trials could strengthen her contributions. Further international collaborations in retinal and uveitic research would provide opportunities for greater visibility and further validation of her findings.

Education:

Dr. Priya Samalia completed her medical degree (MBChB) at the University of Otago, followed by a postgraduate diploma in Ophthalmic Basic Sciences (PGDipOphthBS) in 2014. She continued her academic journey with a PhD in Ophthalmology, awarded in 2013, also from the University of Otago. Her doctoral research further deepened her understanding of uveitis and other ophthalmic conditions. Dr. Samalia then pursued the Royal Australian and New Zealand College of Ophthalmologists’ (RANZCO) Vocational Program, which she completed with advanced clinical examinations in 2019. She was admitted as a Fellow of RANZCO in October 2021. Throughout her education, she received numerous accolades, including the Tassell Postgraduate Scholarship Award (2012) and the Genesis PhD Scholarship Award (2009-2010), demonstrating her commitment to research and academic excellence. Her robust academic foundation underpins her clinical practice and research contributions.

Experience:

Dr. Priya Samalia has extensive experience as an Ophthalmologist, with roles across various prestigious hospitals and health organizations in New Zealand. Since May 2022, she has been a part-time contractor ophthalmologist at Te Whatu Ora Health New Zealand in the Capital Coast and Hutt Valley, Wellington, and Te Toka Tumai in Auckland, with additional responsibilities in Southern, Dunedin. Dr. Samalia provides a range of services including macular degeneration treatment, diabetic retinopathy management, cataract surgery, and uveitis treatment, among others. Her roles also extend to academia, where she serves as a Clinical Senior Lecturer at the University of Otago, Christchurch, contributing to the training and mentorship of medical students. Previously, she excelled in various high-demand clinical settings, consistently demonstrating high productivity, efficiency, and a commitment to patient care. She is known for her collaborative approach and ability to manage complex cases in a diverse range of settings.

Awards and Honors:

Dr. Priya Samalia has received numerous prestigious awards throughout her academic and professional career. In 2012, she was honored with the Tassell Postgraduate Scholarship Award, followed by the Genesis PhD Scholarship Award in 2009 and 2010. These accolades supported her research and development in the field of ophthalmology, particularly in uveitis and retinal diseases. Her significant academic achievements culminated in her admission as a Fellow to the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO) in October 2021. She has been recognized not only for her clinical expertise but also for her leadership in ophthalmic research and education. Her consistent commitment to excellence in patient care and her contributions to advancing knowledge in the field have solidified her position as a respected leader within New Zealand’s ophthalmology community. These awards reflect her dedication to the field, both in clinical practice and in research.

Research Focus:

Dr. Priya Samalia’s research focus lies primarily in the areas of uveitis, retinal diseases, and cataract surgery. She has contributed significantly to understanding the diagnosis, management, and treatment of uveitis, particularly sarcoid uveitis and the role of immunomodulatory treatments in its management. Dr. Samalia is also involved in exploring long-term outcomes of various ophthalmic conditions, including those in pediatric populations and those with retinal vascular diseases. Her work has resulted in publications in high-impact journals such as the British Journal of Ophthalmology and Clinical and Experimental Ophthalmology, with a focus on improving patient care through evidence-based findings. She is particularly interested in the interaction of systemic health with ocular inflammation and the role of immunotherapy in managing complex cases. As a researcher and educator, Dr. Samalia actively contributes to advancing ophthalmic knowledge, training the next generation of ophthalmologists while focusing on improving clinical outcomes for patients.

Publications Top Notes:

  1. Use of Immunomodulatory Treatment for Non-Infectious Uveitis: An International Ocular Inflammatory Society Report of Real-World Practice 🧑‍🔬📑
  2. Insights into the Diagnosis and Management of Sarcoid Uveitis: A Review 🔬🩺
  3. Letter to the Editor: Comment on Raad et al’s “Adalimumab for the Treatment of Non-Infectious Uveitis: A Real Life Experience” 💬📬
  4. Uveitis and Scleritis as a Risk Factor for Mortality ⚰️🔬
  5. Long Term Outcome and Prognostic Indicators in Posner Schlossman Syndrome 🏥👁️
  6. The Spectrum of Paediatric Uveitis in New Zealand 👶🩺
  7. Acute Posterior Multifocal Placoid Pigment Epitheliopathy: Clinical Presentation and Risk of Stroke and Transient Ischaemic Attack 🧠⚠️
  8. Clinical Assessment in Uveitis 🔍📖
  9. Cataract Surgery in Uveitis 👁️🛠️
  10. Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis: Clinical Improvement with Infliximab 💉👁️

Conclusion:

Dr. Priya Samalia is highly deserving of the Research for Best Researcher Award. Her robust academic background, impressive clinical expertise, and significant research contributions make her a leading figure in ophthalmology. Her work not only enhances patient care but also contributes to advancing scientific understanding in the field.